The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy
{{output}}
Antibody-Drug Conjugates (ADCs) have achieved significant success in cancer therapy by combining the targeting specificity of monoclonal antibodies with cytotoxic payloads. However, the concomitant issue of drug resistance has become increasingly prominent, wi... ...
